Phase II multicenter randomized trial evaluating the association of PIPAC and systemicchemotherapy versus systemic chemotherapy alone as 1st-line treatment of MalignantPeritoneal Mesothelioma
Phase 1
Active, not recruiting
- Conditions
- Malignant Peritoneal MesotheliomaMedDRA version: 21.0Level: LLTClassification code: 10034670Term: Peritoneal mesothelioma malignant localised Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10034669Term: Peritoneal mesothelioma malignant advanced Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2024-515343-39-00
- Lead Sponsor
- Institut Regional Du Cancer De Montpellier
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method